SR-4835 T8325
Specifications
| 1mg/5mg/10mg/25mg/50mg/100mg |
Bioactivity:
SR-4835 is a highly selective dual inhibitor of CDK12 and CDK13(CDK12: IC50=99 nM, Kd=98 nM; CDK13: Kd=4.9 nM), which disables triple-negative breast cancer (TNBC) cells
CAS nr:
2387704-62-1
Purity:
98%
Molecular Weight:
499,36
SMILES:
Cn1cc(cn1)-n1cnc2c(NCc3nc4cc(Cl)c(Cl)cc4[nH]3)nc(nc12)N1CCOCC1
Formula:
C21H20Cl2N10O
Pathway:
Cell Cycle/Checkpoint,Apoptosis
Target:
CDK,Apoptosis
